全文获取类型
收费全文 | 167篇 |
免费 | 0篇 |
国内免费 | 2篇 |
专业分类
教育 | 126篇 |
科学研究 | 36篇 |
体育 | 5篇 |
综合类 | 1篇 |
信息传播 | 1篇 |
出版年
2022年 | 1篇 |
2021年 | 3篇 |
2020年 | 1篇 |
2016年 | 4篇 |
2015年 | 4篇 |
2014年 | 8篇 |
2013年 | 8篇 |
2012年 | 7篇 |
2011年 | 9篇 |
2010年 | 7篇 |
2009年 | 10篇 |
2008年 | 4篇 |
2007年 | 11篇 |
2006年 | 19篇 |
2005年 | 12篇 |
2004年 | 11篇 |
2003年 | 11篇 |
2002年 | 10篇 |
2001年 | 16篇 |
2000年 | 1篇 |
1999年 | 4篇 |
1998年 | 1篇 |
1997年 | 1篇 |
1994年 | 3篇 |
1992年 | 3篇 |
排序方式: 共有169条查询结果,搜索用时 281 毫秒
81.
In this study, we examined the expression of inducible nitric oxide synthase (iNOS) and vascular endothelial growth factor
(VEGF) by immunohistochemical staining in 76 tissue sections collected from hepatocellular carcinoma (HCC) patients undergoing
hepatectomy. Microvascular density (MVD) was determined by counting endothelial cells immunostained using anti-CD34 antibody.
We performed DNA-flow cytometric analyses to elucidate the impact of iNOS and VEGF expression on the cell cycle of HCC. Most
of the HCC cells that invaded stroma were markedly immunostained by iNOS antibody. The iNOS stain intensity of the liver tissue
close to the tumor edge was stronger than that of HCC tissue, and the strongest was the hepatocytes closer to the tumor tissue.
However, iNOS expression in 10 normal hepatic samples was undetectable. VEGF positive expression ratio was 84.8% in iNOS positive
expression cases, and the ratio was 35.3% in negative cases. There was significant correlation (P=0.000) between iNOS and VEGF expression. Moreover, iNOS expression was significantly associated with bcl-2 and MVD, but without
p53 expression. DNA-flow cytometric analyses showed that combined expression of iNOS and VEGF had significant impact on the
cell cycle in HCC. PI (Proliferating Index) and SPF (S-phase fraction) in the combined positive expression of iNOS and VEGF
group was significantly higher than that in the combined negative group. The present findings suggested that iNOS expression
was significantly associated with angiogenesis, bcl-2 and cell proliferation of HCC.
Project supported in part by the National Ninth-Five-Years Project Fund (No. 96909121), China 相似文献
82.
目的:探讨腹腔镜与开腹手术治疗卵巢良性畸胎瘤患者对其机体免疫功能造成的影响。方法:研究组卵巢良性畸胎瘤患者给予腹腔镜手术剥除治疗;对照组卵巢良性畸胎瘤患者给予传统开腹手术剥除治疗。观察并记录两组患者治疗前后机体中IL-6(白细胞介素)与T淋巴细胞亚群(CD4/CD8)的含量,并进行统计学分析。结果:研究组与对照组患者治疗前IL-6、CD4/CD8检测结果无明显差异,且P〉0.05,两组患者对比结果无统计学意义;研究组与对照组患者手术后1d与手术后4d IL-6、CD4/CD8检测结果有明显差异,且研究组患者术后4d基本恢复术前水平,P〈0.05,两组患者对比结果有统计学意义。结论:使用腹腔镜治疗卵巢良性畸胎瘤对患者造成的机体免疫功能影响较传统开腹手术小,有利于患者术后恢复机体健康以及预防各类并发症,值得临床推广应用。 相似文献
83.
目的评价三维适形后程加速超分割放射治疗食管癌的疗效及放疗反应、并发症。方法2002年2月至2004年5月,71例食管鳞癌随机分成两组,三维适形后程加速超分割组36例,食管病变上下外约4cm,前后、左右外约0.5~1cm作为PTV1,每次2GY,每周5次,DT40GY后,病变上下外约2cm,前后、左右外约0.5~1cm作为PTV2,每日2次,每次1.5GY,间隔4~6小时,总疗程6周,总剂量67GY/38次。非三维适形后程加速超分割组35例,时间、剂量、分割方式同适形组。所有病例均采用8MV-X外照射。结果1、2、3年的生存率和原发肿瘤的局控率,与非适形后程加速超分割比较,适形组明显提高,分别为88.9%、75%、63.9%比68.6%、51.4%、40%和86.1%、72.2%、58.3%比65.7%、48.5%、34.3%。适形组的急性放射反应明显低于非适形后程加速超分割组,两组有显著差别。结论本研究的初步结果表明食管癌适形后程加速超分割放射治疗的疗效优于非适形后程加速超分割组。 相似文献
84.
营养风险是指现存的或潜在的与营养因素相关的导致患者出现不良临床结局的风险。结直肠癌是常见的恶性肿瘤,在我国发病率逐年升高,由于生理病理原因,以及治疗方法使其更易存在营养风险。现将营养风险及其筛查常用工具进行简单综述,并重点综述结直肠癌营养风险筛查2002(NRS 2002)的应用现状,以期指导临床实践。 相似文献
85.
Yousef Rezaei Chianeh Rashmi Manjunath Krishnananda Prabhu Donald Fernandes M. Vidyasagar Asha Kamath 《Indian journal of clinical biochemistry : IJCB》2014,29(2):238-241
Oral squamous cell carcinoma is one of the most common malignancies recognized. Biomarkers which can predict presence of cancer and its progression can help in better management of these disorders. Over production of lipid peroxidation byproducts and disturbances in antioxidant defense system have been implicated in the pathogenesis of several diseases including oral cancer. Studies have shown a correlation of butyrylcholinesterase (BChE), with tumourigenesis, cell proliferation and cell differentiation. Earlier we have observed a significant elevation in plasma BChE and protein thiols in oral cancer patients which correlated well with stages of cancer. As it was not clear whether the above markers will be altered in saliva of oral cancer patients this study was undertaken. Institutional Ethics Committee gave permission to carry out this study. Total of 55 subjects comprising healthy controls (n = 30) and biopsy proven oral cancer patients (n = 25) consented to participate in this study. Salivary samples from cases were taken before any definitive treatment. Protein thiols and BChE were estimated in salivary samples using validated assay methods. Oral cancer patients had a significant increase in pre-treatment salivary BChE levels (p ≤ 0.001) and a significant decrease (p ≤ 0.001) in salivary thiols as compared to respective values in controls. Salivary protein thiols and BChE may have a role in pathophysiology of oral cancer. Saliva can be used as a potential non-invasive screening tool in oral cancer patients. 相似文献
86.
Anindya Dasgupta Aparna Khan Ushasi Banerjee Mrinalkanti Ghosh Mrinal Pal Kanika M. Chowdhury Sayantan Dasgupta 《Indian journal of clinical biochemistry : IJCB》2013,28(2):169-176
The purpose of this study was to assess the predictive values of central obesity and hyperandrogenemia in development of insulin resistance and dyslipidemia in the polycystic ovarian syndrome (PCOS) patients in our region. Differences of fasting blood glucose level, insulin resistance index HOMA-IR, lipid parameters, waist hip ratio (WHR), body mass index, LH/FSH ratio and testosterone levels between 45 PCOS cases and 35 age matched controls were obtained. Strength of association between different parameters in the case group was assayed by Pearson’s correlation analysis. Dependence of insulin resistance and WHR on different predictors was assessed by multiple linear regression assay. Total cholesterol, LDL cholesterol, LH, FSH, LH/FSH ratio, WHR and insulin resistance were significantly higher in the case group (p < 0.05). Serum testosterone showed strong correlation with insulin resistance and LH/FSH ratio (r = 0.432 and 0.747, p = 0.01 and 0.001 respectively) in the PCOS patients while WHR and serum testosterone level stood out to be most significant predictors for the insulin resistance (β = 0.361 and 0.498; p = 0.048 and 0.049 respectively). Hyperandrogenemia and central obesity were the major factors predicting development of insulin resistance and its related metabolic and cardiovascular complications in our PCOS patients. We suggest early monitoring for androgen level and WHR in these patients for predicting an ensuing insulin resistance and modulating the treatment procedure accordingly to minimise future cardiovascular risks. 相似文献
87.
88.
目的探讨大肠癌组织中CD105和Ki-67的表达及其意义。方法采用免疫组织化学PV-9000法检测50例大肠癌组织和10例正常大肠黏膜组织中CD105和Ki-67的表达,检测肿瘤内微血管密度(MVD)以及计算增殖指数(PI)。结果Ki-67和CD105在大肠癌组织中呈高表达(51.34±24.44,16.44±6.33),与正常黏膜组织中的表达(21.10±8.66,4.00±1.25)相比较,差异有极显著的统计学意义(P〈0.01)。Ki-67的表达与大肠癌的分化程度、临床分期和淋巴结的转移有关,有显著统计学意义(P〈0.05)。MVD与大肠癌的分化程度、临床分期有关(P〈0.05),但与淋巴结转移无关(P〉0.05)。Ki-67在大肠癌高微血管密度组的表达(68.28±16.91)明显高于低微血管密度组(30.59±13.90),差异非常显著(P〈0.01),Ki钾的表达与MYD呈正相关(r=0.28,P〈0.01))。结论CD105和Ki-67在大肠腺癌的发生发展中起着重要作用,并且同时检测两者的表达对大肠腺癌的抗血管治疗和判断其预后有一定应用价值。 相似文献
89.
V. Thakur A. K. Anand U. Mukherjee D. Ghosh 《Indian journal of clinical biochemistry : IJCB》2003,18(2):27-33
Appropriate therapeutic measures can improve the life expectancy of patients with ovarian malignancy. There has been a pressing
need for serodiagnostic assays to enable, the close patient monitoring. Cancer Antigen 125 (CA125) has been described as a
useful marker in patient monitoring for ovarian malignancy. Keeping this in view, the present study was planned. 40 consecutive
female patients of ovarian carcinoma (mean age 52.4±10.7 years) were selected for serum CA125 analysis during the period of
year 1995–2001. The tumour marker concentration was compared with histologic types of ovarian tumour and the FIGO staging
of the disease. 25 healthy females (mean age 35.2–10.4 years) served as control. Mean serum CA125 concentrations in patients
with papillary serous adenocarcinoma(Mean±%CV 1571±121.5 U/ml) was much higher than patients with mucinous adenocarcinoma(775±78U/ml).
Mean serum CA125 concentration in endometrioid carcinoma was very high(2853±136 U/ml). The patient with clear cell carcinoma
however had shown moderate increase(60 U/ml). No correlation was found between serum CA125 concentration and the FIGO staging
of disease.
Quantitation of CA125 was most helpful in monitoring the response of treatment and followup of the patients after completion
of their treatment. Posttherapeutically its concentration showed more than 50% reduction in almost all (91.4%) patients (P<0.001).
Importantly these patients had also shown significant regression of the disease clinically and radiologically. 8.6% of patients
had shown static or increase in serum CA125 concentration which was associated with either clinically static or progressive
disease. Recurrence of the disease was noted in patients who had shown increase in serum CA125 concentration (biochemical
recurrence) in the followup
However, in our test population biochemical recurrence(increase in serum marker concentration) preceded the clinical or radiological
recurrence by an average of 6.5 months.
Kaplan meier survival analysis for evaluation of overall survival in our test subjects showed an overall survival of 32% at
one year and median survival of 9 months with confidence interval of 6.34 to 11.66. We conclude that serum CA125 is a useful
marker for monitoring the treatment and predicting an early recurrence of the disease in ovarian carcinoma patients. A study
in larger number of patients is needed to define its exact role in the management of the carcinoma ovary. 相似文献